Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Suven Pharmaceuticals Ltd (SUVH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
647.50 -12.20    -1.85%
01:57:24 - Real-time Data. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE03QK01018 
S/N:  SUVENPHAR
  • Volume: 169,218
  • Bid/Ask: 646.90 / 647.50
  • Day's Range: 640.05 - 662.00
Suven Pharma 647.50 -12.20 -1.85%

Suven Pharmaceuticals Ltd Company Profile

 
Get an in-depth profile of Suven Pharmaceuticals Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1193

Equity Type

ORD

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. As of September 29, 2023, Suven Pharmaceuticals Limited operates as a subsidiary of Berhyanda Limited.

Contact Information

Address Galaxy Towers 202, A-Wing
Plot No.1, Hyderabad Knowledge City TSIIC, Raidurg Hyderabad,500081
India
Phone 91 40 2354 9414
Fax -

Top Executives

Name Age Since Title
Govinda Prasad Dasu 72 - Independent & Non-Executive Director
Vetukuri Venkata Naga Kali Vara Prasada Raju - 2023 MD & Director
Vaidheesh Annaswamy - 2023 Executive Chairman
Kumarapuram Gopalakrishnan Ananthakrishnan - 2023 Independent Director
Shweta Jalan 48 2023 Non-Executive Director
Abhijit Mukherjee 66 2023 Member of Advisory Council
Vinod Rao 61 2023 Independent Director
Matangi Gowrishankar 66 2023 Independent Director
Pravin Udhyavara Bhadya Rao 63 2023 Independent Director
Pankaj Patwari - 2023 Non-Executive Director
Stefan Stoffel 58 2023 Member of Advisory Council
Venkateswarlu Jasti 75 2019 Member of Advisory Council
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SUVH Comments

Write your thoughts about Suven Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Umesh Goswami
Umesh Goswami Jul 09, 2021 12:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy HINDCOPPER at 145-147 Target 170 to 200++
P k Puri
P k Puri Jan 12, 2021 6:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seems good on chart too, third quarter result will give boost to this share, msy cross 500 after result
Vaibhav Jadhav
Vaibhav Jadhav Dec 27, 2020 11:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy target 540
Pachiappan Aswit
Pachiappan Aswit Jun 19, 2020 8:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target 500
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email